Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Neurosurgery. 2011 Sep;69(3):668–676. doi: 10.1227/NEU.0b013e3182181ba8

Table 1.

Quantitative gadolinium–diethylene triamine pentaacetic acid measurements at 1 and 3 days of infusion.

Time (hours) Vi (mL)a Vd @ 10% (mL)b Ai (μmol)c Ad (μmol)d Cmax (μmol/mL)e
24 21.3 11.6 (54%) 21.3 3.31 0.375
72 65.6 31.0 (47%) 65.6 9.06 0.675
a

Vi = Volume of infusion in milliliters (mL);

b

Vd = Volume of distribution, measured above 10% of the infused concentration;

c

Ai = gadolinium tracer infused in micromoles (μmol);

d

Ad = amount of gadolinium tracer measured;

e

Cmax = peak measured gadolinium concentration.